Unknown

Dataset Information

0

CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.


ABSTRACT: The CRISPR/Cas9 system provides a novel and promising tool for editing the HIV-1 proviral genome. We designed RNA-guided CRISPR/Cas9 targeting the HIV-1 regulatory genes tat and rev with guide RNAs (gRNA) selected from each gene based on CRISPR specificity and sequence conservation across six major HIV-1 subtypes. Each gRNA was cloned into lentiCRISPRv2 before co-transfection to create a lentiviral vector and transduction into target cells. CRISPR/Cas9 transduction into 293?T and HeLa cells stably expressing Tat and Rev proteins successfully abolished the expression of each protein relative to that in non-transduced and gRNA-absent vector-transduced cells. Tat functional assays showed significantly reduced HIV-1 promoter-driven luciferase expression after tat-CRISPR transduction, while Rev functional assays revealed abolished gp120 expression after rev-CRISPR transduction. The target gene was mutated at the Cas9 cleavage site with high frequency and various indel mutations. Conversely, no mutations were detected at off-target sites and Cas9 expression had no effect on cell viability. CRISPR/Cas9 was further tested in persistently and latently HIV-1-infected T-cell lines, in which p24 levels were significantly suppressed even after cytokine reactivation, and multiplexing all six gRNAs further increased efficiency. Thus, the CRISPR/Cas9 system targeting HIV-1 regulatory genes may serve as a favorable means to achieve functional cures.

SUBMITTER: Ophinni Y 

PROVIDER: S-EPMC5958087 | biostudies-other | 2018 May

REPOSITORIES: biostudies-other

altmetric image

Publications

CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.

Ophinni Youdiil Y   Inoue Mari M   Kotaki Tomohiro T   Kameoka Masanori M  

Scientific reports 20180517 1


The CRISPR/Cas9 system provides a novel and promising tool for editing the HIV-1 proviral genome. We designed RNA-guided CRISPR/Cas9 targeting the HIV-1 regulatory genes tat and rev with guide RNAs (gRNA) selected from each gene based on CRISPR specificity and sequence conservation across six major HIV-1 subtypes. Each gRNA was cloned into lentiCRISPRv2 before co-transfection to create a lentiviral vector and transduction into target cells. CRISPR/Cas9 transduction into 293 T and HeLa cells stab  ...[more]

Similar Datasets

| S-EPMC6040082 | biostudies-other
| S-EPMC10025986 | biostudies-literature
| S-EPMC5296774 | biostudies-literature
| S-EPMC7842688 | biostudies-literature
| S-EPMC5780455 | biostudies-literature
| S-EPMC6047682 | biostudies-other
| S-EPMC7693572 | biostudies-literature
| S-EPMC5813945 | biostudies-literature
| S-EPMC6082849 | biostudies-other
| S-EPMC4786927 | biostudies-literature